Robert Ilaria
Plus aucun poste en cours
Fortune : - $ au 31/01/2024
Provenance du réseau au premier degré de Robert Ilaria
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 6 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Robert Ilaria via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| McNeese State University | College/University | Masters Business Admin | |
| Georgetown University | College/University | Undergraduate Degree | |
| Harvard Business School | College/University | Masters Business Admin | |
NeurAxon Pharma, Inc.
 NeurAxon Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services NeurAxon Pharma, Inc. researches and develops nervous system disorder therapies. The company is headquartered in Mississauga, Canada. | Miscellaneous Commercial Services | Chief Executive Officer | |
| AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| MERRIMACK PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| FOGHORN THERAPEUTICS INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
H. Lee Moffitt Cancer Center & Research Institute, Inc.
 H. Lee Moffitt Cancer Center & Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services H. Lee Moffitt Cancer Center & Research Institute, Inc. provides research & contributions to clinical trials, prevention and cancer control. The firm operates as National Cancer Institute (NCI) Comprehensive Cancer Center. The company was founded by Lee H. Moffitt in 1981 and is headquartered in Tampa, FL. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Harvard Law School | College/University | Graduate Degree | |
| Tulane University School of Medicine | College/University | Doctorate Degree | |
| Tulane University School of Public Health & Tropical Medicine | College/University | Graduate Degree | |
| University of South Florida | College/University | Graduate Degree | |
| École Supérieure de Chimie Physique Électronique | College/University | Undergraduate Degree | |
| University of Lausanne | College/University | Doctorate Degree | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor | |
| The Catholic University of America | College/University | Undergraduate Degree | |
| Harvard Medical School | College/University | Doctorate Degree | |
NitroMed, Inc.
 NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA. | Pharmaceuticals: Major | Director of Finance/CFO | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Sales & Marketing | |
| ARQULE, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Cancer Care, Inc.
 Cancer Care, Inc. Hospital/Nursing ManagementHealth Services Cancer Care, Inc. provides cancer treatment services. The firm's services include counseling and support groups, education, financial assistance and practical help. The company was founded in 1944 and is headquartered in New York, NY. | Hospital/Nursing Management | Director/Board Member | |
| ACCELERON PHARMA INC. | Biotechnology | Corporate Officer/Principal | |
| ABBVIE INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| MEI PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
Tmunity Therapeutics, Inc.
 Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Chief Executive Officer | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Sales & Marketing | |
| University of Pretoria | College/University | Doctorate Degree | |
| MEREO BIOPHARMA GROUP PLC | Biotechnology | Director/Board Member | |
| ENLIVEX THERAPEUTICS LTD. | Biotechnology | Director/Board Member | |
| CYCLACEL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| ALAUNOS THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| INTENSITY THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| St. Anselm College | College/University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 32 |
| Canada | 3 |
| France | 2 |
| Suisse | 2 |
| Afrique du Sud | 2 |
Sectorielle
| Health Technology | 18 |
| Consumer Services | 14 |
| Commercial Services | 5 |
| Finance | 3 |
| Health Services | 3 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 10 |
| Director/Board Member | 10 |
| Corporate Officer/Principal | 5 |
| Undergraduate Degree | 5 |
| Independent Dir/Board Member | 4 |
Relations les plus connectées
| Insiders | |
|---|---|
| Sujay Kango | 10 |
| Samuel Agresta | 10 |
| Brian Schwartz | 9 |
| Lawrence Bloch | 8 |
| Paul Melone | 4 |
| Stéphane Peluso | 3 |
- Bourse
- Insiders
- Robert Ilaria
- Connexions Sociétés
